These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
32. Effects of weight loss on nonalcoholic fatty liver disease. Rafiq N; Younossi ZM Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298 [TBL] [Abstract][Full Text] [Related]
33. ASH and NASH. Scaglioni F; Ciccia S; Marino M; Bedogni G; Bellentani S Dig Dis; 2011; 29(2):202-10. PubMed ID: 21734385 [TBL] [Abstract][Full Text] [Related]
34. A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis. Ganguli S; DeLeeuw P; Satapathy SK Hepat Med; 2019; 11():159-178. PubMed ID: 31814783 [TBL] [Abstract][Full Text] [Related]
35. Liver transplantation and non-alcoholic fatty liver disease. Zezos P; Renner EL World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437 [TBL] [Abstract][Full Text] [Related]
36. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate? Byrne CD; Targher G Diabetologia; 2016 Jun; 59(6):1141-4. PubMed ID: 27053232 [TBL] [Abstract][Full Text] [Related]